Crossing the Western Borders: Women of Son

While Turkish television shows have been quite popular in the Middle East, the Balkans, and South America, Turkish producers have been less successful in exporting content to the Western European and North American markets. After receiving moderate ratings in Turkey, Son (2012) was the first Turkish show to be sold to Western Europe when the Swedish public television stv2 purchased the rights to air it with subtitles. While the American adaptation, Runner, did not make it on air on ABC despite the pilot order, the Dutch and the Spanish adaptations were filmed in 2016 and 2017, respectively. Son (The End) remains the only success story among other attempts to introduce Turkish shows into these new markets. In this article, I argue that Son’s two opposing female characters offer a reflexive discussion of Turkey’s identity, and that this allegorical representation, which anchors the story in the current geopolitical climate—mirroring Turkey’s role as an east-west bridge—enables the show to challenge the existing borders of travel for Turkish TV shows

Spectrophotometric determination of the pKapK_a values of some aminoacid complexes of pentacyanoferrate (II) and pentacyanoruthenate (II)

The syntheses, $pK_a$ and spectrospcopic characterization of $[Fe(CN)_5(H_2O)]^{-3}$ and $[Ru(CN)_5(H_2O)]^{-3}$ complexes of alanine(Ala), glycine(Gly), valine(Val), lysine(Lys), arginine(Arg) and cysteine(Cys) complexes were investigated in aqueous solution. The spectra of the complexes containing amino acid ligands were similar to that of $[Fe(CN)_5(H_2O)]^{-3}$. The $pK_a$ values of the complexes were measured by spectrophotometric titration at $22^\circ C$ and $\mu =0.100 M(NaClO_4)$.The syntheses, $pK_a$ and spectrospcopic characterization of $[Fe(CN)_5(H_2O)]^{-3}$ and $[Ru(CN)_5(H_2O)]^{-3}$ complexes of alanine(Ala), glycine(Gly), valine(Val), lysine(Lys), arginine(Arg) and cysteine(Cys) complexes were investigated in aqueous solution. The spectra of the complexes containing amino acid ligands were similar to that of $[Fe(CN)_5(H_2O)]^{-3}$. The $pK_a$ values of the complexes were measured by spectrophotometric titration at $22^\circ C$ and $\mu =0.100 M(NaClO_4)$

Açık Kaynak Kodlu Öğrenme Yönetim Sistemleri Üzerine Bir Karşılaştırma Çalışması

Web tabanlı uzaktan eğitim son yıllarda, üniversitelerin, eğitim organizasyonlarının ve kamu ya da özel birçok kuruluşun, çeşitli (çalışan, bedensel engeli olan, bulunduğu yerde eğitim alma olanağı bulunmayan kişilere bu hizmeti vermek veya zamandan kazanmak ve maliyetleri azaltmak gibi) sebeplerle tercih ettikleri bir çözüm haline gelmiştir. Web tabanlı eğitimde, öğretim materyallerinin öğrencilere sunumu, çeşitli kurs kataloglarını yönetme, sınavlar hazırlama ve uygulama, öğrencilerin öğrenme sürecini kayıt altına alma gibi öğrenme aktivitelerinin yönetimi, raporlama işlemlerinin gerçekleştirilmesi ve eğitim faaliyetlerinin sistematik ve planlı bir şekilde sürdürülebilmesi için Öğrenme Yönetim Sistemleri(ÖYS)’nden yararlanılmaktadır. Günümüzde birçok ticari ÖYS'nin yanı sıra çok sayıda açık kaynak kodlu ÖYS de bulunmaktadır. Açık kaynak kodlu ÖYS'ler; açık kaynak kodu felsefesinin gücü, esnekliği ve bu sistemleri kullanan kişilerin tercihi doğrultusunda ticari ürünlere rakip olabilmektedir. Bu çalışmada; alanyazın taraması sonucunda en sık karşılaşılan Moodle, Sakai, ATutor, Dokeos, Claroline ve OLAT ÖYS'leri, araştırmacılar tarafından geliştirilen "ÖYS Değerlendirme ve Seçim Envanteri" kullanılarak incelenmiş ve değerlendirme sonuçları karşılaştırılmıştır. Araştırma sonuçlarının gerek üniversitelerin ve eğitim organizasyonlarının gerekse kamu ve özel kuruluşların ÖYS seçim ve karar verme sürecine rehberlik etmesi amaçlanmaktadır

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: A Turkish Oncology Group study

Aims: In this multicenter study, the authors aimed to determine the real-life efficacy and safety of first-line alectinib. Materials & methods: This retrospective trial included advanced-stage, ALK-positive non-small-cell lung cancer patients who were treated with first-line alectinib in terms of ALK-tyrosine kinase inhibitors, regardless of previous chemotherapy. The co-primary end points were progression-free survival both for all patients and for the treatment-naive population. The secondary end points were overall response rate, overall survival, rate of CNS progression and safety. Results & conclusion: A total of 274 patients (n = 177 for treatment-naive patients) were enrolled in the study. The median progression-free survival was 26 and 28.8 months for all patients and the treatment-naive group, respectively. The overall response rate, CNS progression rate and 1-year overall survival ratio were 77.9, 12.4 and 77%. Alectinib is a highly effective therapy with a favorable safety profile